Mania News and Research

RSS

Impulsivity in bipolar disorder unrelated to substance abuse

Trait impulsivity is elevated and neurocognitive functioning is impaired in patients with bipolar disorder irrespective of whether they have a substance abuse history, research shows.

20 Sep 2013

Guidance for medication in bipolar depression published

Solid evidence to guide the use of antidepressants in patients with bipolar disorder is “remarkably limited,” says the International Society for Bipolar Disorders Task Force.

18 Sep 2013

Depression highlighted as nonadherence risk in bipolar patients

The presence of residual depressive symptoms may result in patients with bipolar disorder being nonadherent to their medication, study findings suggest.

12 Sep 2013

Exercise may not be ‘one size fits all’ in bipolar patients

Researchers say that more study is needed of the relationship between exercise and symptoms among patients with bipolar disorder.

6 Sep 2013

Improved pediatric bipolar screen unveiled

Researchers have developed a screening instrument for detecting bipolar disorder in children and adolescents from the general population.

30 Aug 2013

Identifying bipolarity through MRI's proves successful in initial results

What are some of the most troubling numbers in mental health? Six to 10 -- the number of years it can take to properly diagnose a mental health condition. Dr. Elizabeth Osuch, a Researcher at Lawson Health Research Institute and a Psychiatrist at London Health Sciences Centre and the Department of Psychiatry at Western University, is helping to end misdiagnosis by looking for a 'biomarker' in the brain that will help diagnose and treat two commonly misdiagnosed disorders.

16 Aug 2013

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

26 Jul 2013

Women at high risk of postpartum psychosis need very careful care, says new review

There are clear risk factors for postpartum psychosis that all women should be asked about antenatally to ensure early recognition and prompt treatment of the condition, says a new review published today (12 July) in The Obstetrician & Gynaecologist.

15 Jul 2013

Low-dose ketamine anesthetic has potential to alleviate severe depression

Low-dose intravenous infusions of ketamine, a general anesthetic used in minor surgeries, given over a long period are an effective treatment for depression, Mayo Clinic researchers found. The study is published in the Journal of Psychopharmacology.

5 Jun 2013

Antidepressants cause mood elevation and behavioral activation in children and adolescents

A paper published in the current issue of P&P by a group of researchers of the University of Bologna (headed by Professor Giovanni Fava) and a Harvard psychopharmacologist (professor Ross Baldessarini) has analyzed data that derive from randomized controlled trials concerned with the use of antidepressant drugs in children and adolescents.

27 May 2013

Viewpoints: Controversy taints IRS efforts on health law; Another chance to 'gut' the overhaul in the courts; Salt wrongly accused

Even as the politicized tax enforcement scandal expands, the Internal Revenue Service continues to expand its political powers thanks to the Affordable Care Act. A larger government always creates more openings for abuse, as Americans will learn when the IRS starts auditing their health care in addition to their 1040 next year (5/14).

16 May 2013

Continuous circular cycling ‘a distinct bipolar disorder subtype’

Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.

30 Apr 2013

Religiosity may influence depression, QoL in bipolar disorder

Results from a Brazilian study suggest that higher levels of intrinsic religiosity are associated with fewer depressive symptoms and increased quality of life in patients with bipolar disorder.

29 Apr 2013

Electroconvulsive therapy improves quality of life in patients with severe depression

Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.

16 Apr 2013

Study explores a better alternative for treating bipolar disorder

Toxicity problems and adverse side effects when taking lithium, the mainstay medication for treating bipolar disorder, are fostering a scientific hunt for insights into exactly how lithium works in the body - with an eye to developing a safer alternative.

28 Mar 2013

Majority of women have postpartum depressive symptoms, finds study

A surprisingly high number of women have postpartum depressive symptoms, according to a new, large-scale study by a Northwestern Medicine- researcher.

15 Mar 2013

Family-focused therapy improves mood symptoms in youth at risk of bipolar disorder

A study published in the February 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that children and adolescents with major depression or subthreshold forms of bipolar disorder - and who had at least one first-degree relative with bipolar disorder - responded better to a 12-session family-focused treatment than to a briefer educational treatment.

8 Mar 2013